L815-0150 Screening compound: (2E)-N-[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-3-phenylprop-2-enamide

L815-0150 Screening compound: (2E)-N-[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-3-phenylprop-2-enamide
L815-0150 Screening compound: (2E)-N-[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-3-phenylprop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L815-0150
(2E)-N-[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-3-phenylprop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L815-0150

Molecular Formula

C20H20N2O2 (C20 H20 N2 O2)

Compound Name

(2E)-N-[2-oxo-2-(1,2,3,4-tetrahydroquinolin-1-yl)ethyl]-3-phenylprop-2-enamide

IUPAC name

(2E)-N-[2-oxo-2-(1234-tetrahydroquinolin-1-yl)ethyl]-3-phenylprop-2-enamide

SMILES

O=C(CNC(/C=C/c1ccccc1)=O)N(CCC1)c2c1cccc2

InChI

InChI=1S/C20H20N2O2/c23-19(13-12-16-7-2-1-3-8-16)21-15-20(24)22-14-6-10-17-9-4-5-11-18(17)22/h1-5,7-9,11-13H,6,10,14-15H2,(H,21,23)

InChI Key

OCRQLNABYGOITQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27477136

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

320.39

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.436

Distribution Coefficient, logD

3.436

Water Solubility, LogSw

-3.55

Polar Surface Area

39.495

Acid Dissociation Constant (pKa)

12.65

Base Dissociation Constant (pKb)

-0.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

L815-0150 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Structure:
  • Cyclic compounds
  • 3D
  • Fragments
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L815-0150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L815-0150?
Check Price and Availability of L815-0150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L815-0150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L815-0150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L815-0150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L815-0150 available by request